Isolated Systolic Hypertension in Young People Is Not Spurious and Should Be Treated

DOI Web Site 被引用文献1件
  • Carmel M. McEniery
    From the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK (C.M.M., I.B.W.); Heart Disease Prevention Program, University of California, Irvine (S.S.F.); and Cardiff School of Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom (J.R.C.).
  • Stanley S. Franklin
    From the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK (C.M.M., I.B.W.); Heart Disease Prevention Program, University of California, Irvine (S.S.F.); and Cardiff School of Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom (J.R.C.).
  • John R. Cockcroft
    From the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK (C.M.M., I.B.W.); Heart Disease Prevention Program, University of California, Irvine (S.S.F.); and Cardiff School of Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom (J.R.C.).
  • Ian B. Wilkinson
    From the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK (C.M.M., I.B.W.); Heart Disease Prevention Program, University of California, Irvine (S.S.F.); and Cardiff School of Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom (J.R.C.).

書誌事項

タイトル別名
  • Pro Side of the Argument

収録刊行物

  • Hypertension

    Hypertension 68 (2), 269-275, 2016-08

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ